CoreCap Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Buy
2,450
+555
+29% +$36.5K ﹤0.01% 938
2026
Q1
$135K Buy
1,895
+43
+2% +$3.39K ﹤0.01% 929
2025
Q4
$152K Buy
1,852
+568
+44% +$44.3K 0.01% 882
2025
Q3
$96.5K Buy
1,284
+3
+0.2% +$224 ﹤0.01% 1056
2025
Q2
$94.9K Buy
1,281
+44
+4% +$3.06K ﹤0.01% 1003
2025
Q1
$99.9K Buy
1,237
+5
+0.4% +$430 ﹤0.01% 910
2024
Q4
$96.3K Sell
1,232
-588
-32% -$50K ﹤0.01% 943
2024
Q3
$171K Sell
1,820
-81
-4% -$6.8K 0.01% 738
2024
Q2
$148K Sell
1,901
-879
-32% -$71.7K 0.02% 418
2024
Q1
$253K Buy
+2,780
New +$231K 0.01% 563

Other funds holding GEHC

CoreCap Advisors's GEHC Position: Q2 2026 in Review

CoreCap Advisors increased its GE HealthCare (GEHC) stake by 29% in Q2 2026, buying an estimated $36.5K and bringing the position to 2,450 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

CoreCap Advisors first reported a position in GEHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $253K in Q1 2024. 276 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • CoreCap Advisors held 2,450 shares of GE HealthCare worth $157K as of Q2 2026.
  • CoreCap Advisors bought 555 GE HealthCare shares in Q2 2026, an estimated $36.5K.
  • GE HealthCare made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #938 holding.
  • CoreCap Advisors first reported a position in GE HealthCare in Q1 2024 and has held it in 10 quarters since.
  • CoreCap Advisors's GE HealthCare position peaked at $253K in Q1 2024.
  • 276 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.